Literature DB >> 20869251

Matched-pair total knee arthroplasty retrieval analysis: oxidized zirconium vs. CoCrMo.

Thomas J Heyse1, Dan X Chen, Natalie Kelly, Friedrich Boettner, Timothy M Wright, Steven B Haas.   

Abstract

Oxidized zirconium (OxZr) was introduced to serve as a ceramic surface for femoral components in TKA. The aim of this study was to compare retrieved OxZr components and corresponding PE inserts in matched comparison with conventional cobalt/chrome/molybdenum alloy (CoCrMo). Eleven retrieved posterior stabilized TKA with an OxZr femoral component were included. This included 6 implants from an earlier preliminary study. From a cohort of 56 retrieved TKA with conventional CoCrMo femoral components, pairs were matched according to duration of implantation, patient age, reason for revision, and BMI. Polyethylene inlays and femoral components were optically scored for in vivo damage. The average damage score of the tibial PE inserts was significantly lower with OxZr components (p=0.01). Mainly burnishing and scratches were found. The average wear score in the visual analysis of the femoral components was significantly lower for the OxZr as well (p=0.005). Femoral components made of OxZr were less sensitive to in vivo damage and corresponding PE inlays also showed less damage than CoCrMo components.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20869251     DOI: 10.1016/j.knee.2010.08.011

Source DB:  PubMed          Journal:  Knee        ISSN: 0968-0160            Impact factor:   2.199


  8 in total

1.  The 2012 Mark Coventry award: a retrieval analysis of high flexion versus posterior-stabilized tibial inserts.

Authors:  Nicholas R Paterson; Matthew G Teeter; Steven J MacDonald; Richard W McCalden; Douglas D R Naudie
Journal:  Clin Orthop Relat Res       Date:  2013-01       Impact factor: 4.176

2.  Exposure of articular chondrocytes to wear particles induces phagocytosis, differential inflammatory gene expression, and reduced proliferation.

Authors:  Michael D Kurdziel; Meagan Salisbury; Lige Kaplan; Tristan Maerz; Kevin C Baker
Journal:  J Mater Sci Mater Med       Date:  2017-05-22       Impact factor: 3.896

3.  The 2018 Mark Coventry, MD Award: Does a Ceramic Bearing Improve Pain, Function, Wear, or Survivorship of TKA in Patients Younger Than 55 Years of Age? A Randomized Trial.

Authors:  Young-Hoo Kim; Jang-Won Park; Jun-Shik Kim
Journal:  Clin Orthop Relat Res       Date:  2019-01       Impact factor: 4.176

4.  Radiostereometric Analysis Permits In Vivo Measurement of Very Small Levels of Wear in TKA.

Authors:  Matthew G Teeter; Jacob Wihlidal; Richard W McCalden; Xunhua Yuan; Steven J MacDonald; Brent A Lanting; Douglas D Naudie
Journal:  Clin Orthop Relat Res       Date:  2019-01       Impact factor: 4.176

5.  Does oxidized zirconium make a difference? Midterm cohort survivorship of symmetric posterior condyle posterior-stabilized total knee arthroplasty

Authors:  A. Ross Demcoe; Eric R. Bohm; David R. Hedden; Colin D. Burnell; Thomas R. Turgeon
Journal:  Can J Surg       Date:  2019-04-01       Impact factor: 2.089

Review 6.  Current status and future potential of wear-resistant coatings and articulating surfaces for hip and knee implants.

Authors:  Charlotte Skjöldebrand; Joanne L Tipper; Peter Hatto; Michael Bryant; Richard M Hall; Cecilia Persson
Journal:  Mater Today Bio       Date:  2022-04-30

7.  Oxidized zirconium versus cobalt-chromium in TKA: profilometry of retrieved femoral components.

Authors:  Thomas J Heyse; Marcella E Elpers; Danyal H Nawabi; Timothy M Wright; Steven B Haas
Journal:  Clin Orthop Relat Res       Date:  2014-01       Impact factor: 4.176

8.  No difference in in vivo polyethylene wear particles between oxidized zirconium and cobalt-chromium femoral component in total knee arthroplasty.

Authors:  Yukihide Minoda; Kanako Hata; Hiroyoshi Iwaki; Mitsuhiko Ikebuchi; Yusuke Hashimoto; Fumiaki Inori; Hiroaki Nakamura
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-10-20       Impact factor: 4.342

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.